scPharmaceuticals SCPH 深 沪
已收盘 10-07 16:00:00 美东时间
5.67
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 5.67
- 总市值 3.04亿
- 52周最高 6.2799
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.94
- 委 比 0.00%
- 总股本 5367.88万
- 历史最高 18.17
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.94
- 每 手 1
- 风险率 1.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MannKind's Afrezza under supplemental FDA review
MannKind Corporation (MNKD) announced that the U.S. FDA has accepted the supplemental marketing application seeking approval for Afrezza (insulin human) inhalation powder in children and adolescents l...
10-13 21:43
scPharmaceuticals Completes Merger and Delists from Nasdaq
The latest update is out from scPharmaceuticals ( ($SCPH) ). On October 7, 2025...
10-07 21:44
scPharmaceuticals Issues Promissory Note to MannKind
The latest update is out from scPharmaceuticals ( ($SCPH) ). On September 23, 2...
09-25 16:25
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRY, SCPH, WKHS on Behalf of Shareholders
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/o...
09-22 20:46
华兴资本医疗与生命科技行业周报【Vol.382】
来源：华兴资本 “华兴资本医疗与生命科技行业周报”定期发布，专注从资本角度解读一周数据，并提供最新行业观察。 医疗与生命科技是华兴资本多年来关注并深耕的领域，目...
09-01 08:30
美股大行评级 | 潜在涨幅163.16%！HIVE Digital Technologies获Roth Capital升目标价至7.5美元，维持"买入"评级
今日重点评级关注：Roth Capital：维持HIVE Digital Technologies"买入"评级，目标价从6美元升至7.5美元；Craig-Hallum：维持Ranpak Hldgs"买入"评级，目标价从8美元升至10美元
08-27 08:32
Craig-Hallum Downgrades scPharmaceuticals to Hold, Announces $6 Price Target
Craig-Hallum analyst Chase Knickerbocker downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold and announces $6 price target.
08-27 02:01
Maxim Group Downgrades scPharmaceuticals to Hold
Maxim Group analyst Naz Rahman downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold.
08-26 02:57
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a $10 billion U.S. market opportunity.
08-26 01:57
scPharmaceuticals Announces Merger with MannKind Corporation
The latest announcement is out from scPharmaceuticals ( ($SCPH) ). On August 24...
08-25 19:59
